General Information of the Compound
| Compound ID |
CP0862445
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-endo-{8-[2-(1-cyclohexylmethyl-3-pentylureido)-ethyl]-8-azabicyclo[3.2.1]oct-3-yl}benzamide
Show/Hide
|
||||||||||||||||||
| Formula |
C29H46N4O2
|
||||||||||||||||||
| Molecular Weight |
482.713
|
||||||||||||||||||
| Canonical SMILES |
CCCCCNC(=O)N(CCN1[C@@H]2CC[C@H]1C[C@@H](c1cccc(C(N)=O)c1)C2)CC1CCCCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H46N4O2/c1-2-3-7-15-31-29(35)32(21-22-9-5-4-6-10-22)16-17-33-26-13-14-27(33)20-25(19-26)23-11-8-12-24(18-23)28(30)34/h8,11-12,18,22,25-27H,2-7,9-10,13-17,19-21H2,1H3,(H2,30,34)(H,31,35)/t25-,26+,27-
Show/Hide
|
||||||||||||||||||
| InChIKey |
GWDBIKQKJSMRNQ-LGKQTMLJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01188, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor